EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis

Erika Morsia, Paola Ranalli, Stefano Baldoni, Stefania Mancini, Sonia Morè, Chiara Cantò, Dorela Lame, Gaetano La Barba, Antonella Poloni, Serena Rupoli, Mauro Di Ianni

Annals of Hematology · 2025-09 · 104 (9) · 4525-4529

DOI: 10.1007/s00277-025-06606-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, online erschienen am 29.09.2025. Verfasst von Erika Morsia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, Via Tronto 10/A, Ancona, 60126, Italy. e.morsia@univpm…. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Janus Kinase 2, Venous Thrombosis, Intracranial Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università Politecnica delle Marche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloproliferative neoplasms (MPNs) are associated with an elevated risk of thrombosis in unusual sites such as the splanchnic vein thrombosis (SVT) and cerebral vein thrombosis (CVT). In patients with unusual site thrombosis, screening for MPNs is routine, but diagnosis is often difficult due to the absence of clear clinical signs or elevated blood counts—frequently leading to an MPN-U classification—while the thrombotic event itself is often the first clue. Furthermore, there is no consensus on treatments beyond anticoagulation, leading to variability across centers. This study investigates the molecular characteristics of MPNs associated with SVT and CVT. We conducted a retrospective, multicenter analysis of 44 patients with MPN and unusual site thrombosis from Italian hematology units, using next-generation sequencing. (NGS) to identify driver and passengers mutations. Our findings confirm a high prevalence of unclassifiable MPN (MPN-U) among SVT patients. JAK2 p.V617F was found in 86.4% of cases, and patients with additional mutations had higher median JAK2 variant allele frequencies. JAK2 p.V617F is known to promote thrombosis by inducing a pro-inflammatory endothelial environment, particularly relevant in low-flow venous sites such as cerebral sinuses and splanchnic veins, supporting MPN screening in these patients. In contrast, data on JAK2 -unmutated cases are more limited, but our cohort suggests a possible association between unusual site thrombosis and a more complex mutational profile involving multiple genetic alterations. TET2 mutations were more frequent in patients with MPN-CVT compared to the rest of the cohort (66.6% vs. 15.7%). Absence of KIT mutations was associated with poorer thrombotic recurrence-free survival, suggesting a negative prognostic role of KIT mutation. Brief report.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloproliferative DisordersJanus Kinase 2Venous ThrombosisIntracranial ThrombosisThrombosisHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultAged, 80 and overMutationHigh-Throughput Nucleotide SequencingItaly

Stichwörter der Autor:innen

Cerebral vein thrombosisMolecular profileMyeloproliferative neoplasmSplanchnic vein thrombosis

Substanzen

Janus Kinase 2JAK2 protein, human

Autor:innen und Institutionen

  • Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, Via Tronto 10/A, Ancona, 60126, Italy. e.morsia@univpm.it.
  • Hematology Clinic, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy. e.morsia@univpm.it.
  • Department of Medicine and Aging Sciences, University "G. D'Annunzio" of Chieti- Pescara, Pescara, Italy.
  • Hematology Unit, S. Spirito Hospital, Pescara, Italy.
  • Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, Via Tronto 10/A, Ancona, 60126, Italy.
  • Hematology Clinic, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.

Förderung

  • Università Politecnica delle Marche

Zitieren

APA

Morsia, E., Ranalli, P., Baldoni, S., Mancini, S., Morè, S., Cantò, C., Lame, D., Barba, G., Poloni, A., Rupoli, S., & Di Ianni, M. (2025). Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis. Annals of Hematology, 104(9), 4525-4529. https://doi.org/10.1007/s00277-025-06606-5

Vancouver

Morsia E, Ranalli P, Baldoni S, Mancini S, Morè S, Cantò C, et al. Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis. Annals of Hematology. 2025;104(9):4525-4529. doi:10.1007/s00277-025-06606-5

BibTeX
@article{Morsia2025,
  author = {Morsia, Erika and Ranalli, Paola and Baldoni, Stefano and Mancini, Stefania and Morè, Sonia and Cantò, Chiara and Lame, Dorela and Barba, Gaetano La and Poloni, Antonella and Rupoli, Serena and Di Ianni, Mauro},
  title = {Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis},
  journal = {Annals of Hematology},
  year = {2025},
  volume = {104},
  number = {9},
  pages = {4525--4529},
  doi = {10.1007/s00277-025-06606-5}
}
Kostenlos starten →